Guido Piontek
Impact in
- Genetics top 5%
- Mesenchymal stem cell research
- Glioma Diagnosis and Treatment
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 24
- Cancer-related Molecular Pathways 10
- HER2/EGFR in Cancer Research 4
- Co-authors
- Jürgen Schlegel (24 shared papers)Heike E. Daldrup‐Link (11 shared papers)Martina Rudelius (17 shared papers)Ernst J. Rummeny (6 shared papers)Marcus Settles (5 shared papers)Anja Pickhard (20 shared papers)Robert A.J. Oostendorp (5 shared papers)Reinhard Meier (5 shared papers)
- Journals
- Oncotarget (7 papers)European Radiology (3 papers)Radiology (3 papers)European Journal of Nuclear Medicine and Molecular Imaging (3 papers)Oral Oncology (2 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Guido Piontek
58 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 109
- Genetics 295
- Biomaterials 254
- Otorhinolaryngology 80
- Oncology 492
- Cancer Research 230
Countries citing papers authored by Guido Piontek
This map shows the geographic impact of Guido Piontek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Piontek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Piontek more than expected).
Fields of papers citing papers by Guido Piontek
This network shows the impact of papers produced by Guido Piontek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Piontek. The network helps show where Guido Piontek may publish in the future.
Co-authors
The 25 scholars most cited alongside Guido Piontek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 168 | |
| 2 | 2005 | 149 | |
| 3 | 2004 | 139 | |
| 4 | 2010 | 126 | |
| 5 | 2010 | 121 | |
| 6 | 2005 | 95 | |
| 7 | 2015 | 78 | |
| 8 | 2004 | 75 | |
| 9 | 2003 | 66 | |
| 10 | 2011 | 59 | |
| 11 | 2008 | 57 | |
| 12 | 2018 | 55 | |
| 13 | 2011 | 50 | |
| 14 | 2010 | 42 | |
| 15 | 2010 | 38 | |
| 16 | Effects of topoisomerase inhibitors that induce DNA damage response on glucose metabolism and PI3K/Akt/mTOR signaling in multiple myeloma cells. | 2015 | 36 |
| 17 | 2006 | 35 | |
| 18 | 1999 | 33 | |
| 19 | 2018 | 32 | |
| 20 | 2000 | 32 |
About Guido Piontek
Guido Piontek is a scholar working on Oncology, Molecular Biology, Surgery, Immunology and Pulmonary and Respiratory Medicine, having authored 58 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (10 papers), Head and Neck Cancer Studies (6 papers), Immune Cell Function and Interaction (5 papers), Microtubule and mitosis dynamics (5 papers), Head and Neck Surgical Oncology (5 papers), HER2/EGFR in Cancer Research (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). The work is most often cited by research in Genetics (295 citations), Biomaterials (254 citations), Otorhinolaryngology (80 citations), Oncology (492 citations) and Cancer Research (230 citations). Guido Piontek has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Jürgen Schlegel, Heike E. Daldrup‐Link, Martina Rudelius, Ernst J. Rummeny, Marcus Settles, Anja Pickhard, Robert A.J. Oostendorp, Reinhard Meier, Thomas M. Link and U. Heinzmann. Their work appears in journals such as Oncotarget, European Radiology, Radiology, European Journal of Nuclear Medicine and Molecular Imaging and Oral Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.